{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05085990",
            "orgStudyIdInfo": {
                "id": "TARA-002-101(Phase 1b)"
            },
            "organization": {
                "fullName": "Protara Therapeutics",
                "class": "INDUSTRY"
            },
            "briefTitle": "Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer",
            "officialTitle": "A Phase 1a/b Dose Finding, Open-label Study to Evaluate Safety and Toxicity of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer",
            "acronym": "ADVANCED-1",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "safety-and-toxicity-study-of-intravesical-instillation-of-tara-in-adults-with-high-grade-non-muscle-invasive-bladder-cancer"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-05-08",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-06",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-08",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-10-07",
            "studyFirstSubmitQcDate": "2021-10-07",
            "studyFirstPostDateStruct": {
                "date": "2021-10-20",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-01",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-03",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Protara Therapeutics",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study is open-label dose expansion study to investigate the safety and toxicity of intravesical treatment of high-grade NMIBC (HGTa or CIS, including CIS with concomitant Ta) after transurethral resection of bladder tumor (TURBT) and/or biopsy using TARA-002 in adults unable to obtain intravesical Bacillus Calmette-Gu\u00e9rin (BCG), adults who have received at least one dose of intravesical BCG or adults who have received at least one dose of intravesical chemotherapy.\n\nAfter completion of the dose escalation phase (Phase 1a) and after the RP2D has been established, the dose expansion phase (Phase 1b) will start enrollment of subjects with CIS NMIBC with active disease to further evaluate the safety and preliminary efficacy of TARA-002, at the established RP2D. CIS NMIBC with active disease is defined as disease present at the last cystoscopic evaluation prior to signing the ICF. Subjects enrolled in the dose expansion phase will not include subjects previously enrolled and treated in the dose escalation phase.\n\nAll subjects will receive 6 weeks of treatment at the established RP2D."
        },
        "conditionsModule": {
            "conditions": [
                "Non-muscle Invasive Bladder Cancer"
            ],
            "keywords": [
                "Non-muscle invasive bladder cancer",
                "bladder cancer",
                "high grade Ta",
                "carcinoma in situ",
                "high-grade NMIBC"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "interventionModelDescription": "All subjects will receive 6 weekly doses of TARA-002 at the recommended Phase 2 dose (R2PD)",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 12,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "TARA-002",
                    "type": "EXPERIMENTAL",
                    "description": "TARA-002 is a lyophilized biological preparation for instillation containing cells of Streptococcus pyogenes (Group A, type 3) Su strain treated with benzylpenicillin.",
                    "interventionNames": [
                        "Biological: TARA-002"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BIOLOGICAL",
                    "name": "TARA-002",
                    "description": "Phase 1b, Dose Expansion Phase: All subjects will receive 6 weekly doses of TARA-002 at the recommended Phase 2 dose (R2PD)",
                    "armGroupLabels": [
                        "TARA-002"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Phase 1b, Dose Expansion Phase: Incidence of AEs in subjects with CIS NMIBC with active disease",
                    "description": "AE = adverse event",
                    "timeFrame": "Day 1 to Day 78"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Male or female subjects 18 years of age or older at the time of signing the informed consent\n* Subjects who have voluntarily given written informed consent after the nature of the study has been explained according to applicable requirements prior to study entry\n* Subjects with a histologically confirmed, high-grade Ta or CIS (including CIS with concomitant Ta) urothelial cell carcinoma of the bladder according to central review\n* Subjects who are treatment na\u00efve, unable to obtain intravesical BCG for the treatment of NMIBC, have received at least one dose of intravesical BCG, or at least one dose of intravesical chemotherapy\n\nExclusion Criteria:\n\n* Penicillin allergy (subjects with a questionable history of allergy to penicillin or no history of penicillin use will undergo penicillin allergy testing prior to inclusion in the study)\n* Predominant (defined as \\> 50%) adenocarcinoma, squamous cell carcinoma, or histological variants including plasmacytoid, sarcomatoid, or squamous components according to central review\n* Concomitant prostatic or upper tract urothelial involvement per Investigator's assessment\n* Nodal involvement or metastatic disease that existed at any time (past or present disease)\n* Bladder cancer stage \u2265 T1 within the last 36 months according to central histology review\n* Bladder cancer stage CIS with concomitant T1\n\nFor more information on eligibility criteria, please contact the sponsor.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Chief Scientific Operations Officer",
                    "role": "CONTACT",
                    "phone": "16468440337",
                    "email": "clinicaltrials@protaratx.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Chief Scientific Operations Officer",
                    "affiliation": "Protara Therapeutics",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "USC Norris Cancer Center",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90089",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Use Central Contact",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "Mayo Clinic",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Jacksonville",
                    "state": "Florida",
                    "zip": "32224",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 30.33218,
                        "lon": -81.65565
                    }
                },
                {
                    "facility": "Tulane Medical Center (TMC) - Clinic/Outpatient Facility",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "New Orleans",
                    "state": "Louisiana",
                    "zip": "70112",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.95465,
                        "lon": -90.07507
                    }
                },
                {
                    "facility": "Chesapeake Urology Research Associates",
                    "status": "COMPLETED",
                    "city": "Baltimore",
                    "state": "Maryland",
                    "zip": "21204",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.29038,
                        "lon": -76.61219
                    }
                },
                {
                    "facility": "Mayo Clinic",
                    "status": "RECRUITING",
                    "city": "Rochester",
                    "state": "Minnesota",
                    "zip": "55905",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Use Central Contact",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.02163,
                        "lon": -92.4699
                    }
                },
                {
                    "facility": "Premier Medical Group of the Hudson Valley",
                    "status": "COMPLETED",
                    "city": "Poughkeepsie",
                    "state": "New York",
                    "zip": "12603",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.70037,
                        "lon": -73.92097
                    }
                },
                {
                    "facility": "University of Rochester, Department of Urology",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Rochester",
                    "state": "New York",
                    "zip": "14642",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 43.15478,
                        "lon": -77.61556
                    }
                },
                {
                    "facility": "Carolina Urologic Research Center",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Myrtle Beach",
                    "state": "South Carolina",
                    "zip": "29572",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.68906,
                        "lon": -78.88669
                    }
                },
                {
                    "facility": "Urology Associates PC",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Nashville",
                    "state": "Tennessee",
                    "zip": "37209",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 36.16589,
                        "lon": -86.78444
                    }
                },
                {
                    "facility": "UT Health San Antonio",
                    "status": "RECRUITING",
                    "city": "San Antonio",
                    "state": "Texas",
                    "zip": "78229",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Use Central Contact",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.42412,
                        "lon": -98.49363
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30",
            "removedCountries": [
                "Moldova, Republic of",
                "Romania"
            ]
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000001749",
                    "term": "Urinary Bladder Neoplasms"
                },
                {
                    "id": "D000093284",
                    "term": "Non-Muscle Invasive Bladder Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000014571",
                    "term": "Urologic Neoplasms"
                },
                {
                    "id": "D000014565",
                    "term": "Urogenital Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000001745",
                    "term": "Urinary Bladder Diseases"
                },
                {
                    "id": "D000014570",
                    "term": "Urologic Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                },
                {
                    "id": "D000002277",
                    "term": "Carcinoma"
                },
                {
                    "id": "D000009375",
                    "term": "Neoplasms, Glandular and Epithelial"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M5030",
                    "name": "Urinary Bladder Neoplasms",
                    "asFound": "Bladder Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5535",
                    "name": "Carcinoma in Situ",
                    "relevance": "LOW"
                },
                {
                    "id": "M2976",
                    "name": "Non-Muscle Invasive Bladder Neoplasms",
                    "asFound": "Non-muscle Invasive Bladder Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17320",
                    "name": "Urologic Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M17315",
                    "name": "Urogenital Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M5026",
                    "name": "Urinary Bladder Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17319",
                    "name": "Urologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12320",
                    "name": "Neoplasms, Glandular and Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M13311",
                    "name": "Penicillin G",
                    "relevance": "LOW"
                },
                {
                    "id": "M13312",
                    "name": "Penicillin G Benzathine",
                    "relevance": "LOW"
                },
                {
                    "id": "M13313",
                    "name": "Penicillin G Procaine",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}